Already a member? Sign in
Oxycontin is a brand name for the extended release preparation of the drug oxycodone, a narcotic analgesic drug used to treat or prevent moderate to severe pain. Oxycontin is a brand name owned by Purdue Pharmaceuticals.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Pain | 143 | 28 |
|
|
|
||
| Chronic pain | 110 | 28 |
|
|
|
||
| Fibromyalgia | 48 | 13 |
|
|
|
||
| Other | 20 | 5 |
|
|
|||
| Pain in lower back | 13 | 9 |
|
|
|
|
|
| Muscle and joint pain | 7 | 1 |
|
See all 285 patients currently taking Oxycontin
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Oxycontin
| Constipation | 25 | |
|---|---|---|
| Slowed thinking | 11 | |
| Slow speech (bradyarthria) | 11 | |
| Excessive daytime sleepiness (somnolence) | 9 | |
| Drugged feeling | 8 | |
| Itching (pruritus) | 7 | |
| See all 31 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Oxycontin. See all 39 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 25 | ||
| Side effects too severe | 23 | ||
| Doctor's advice | 23 | ||
| Other | 21 | ||
| Expense | 10 | ||
| Personal research | 7 | ||
| Course of treatment ended | 4 | ||
| Change in health plan coverage | 4 | ||
| Not indicated | 2 |
Adherence
Taking treatment as prescribed
Adherence of Oxycontin
Always |
59 | 79% |
|
|---|---|---|---|
Usually |
10 | 13% |
|
Sometimes |
5 | 7% |
|
Never |
1 | 1% |
|
Burden
Difficulty being on treatment
Burden of Oxycontin
Very |
7 | 9% |
|
|---|---|---|---|
Somewhat |
12 | 16% |
|
A little |
15 | 20% |
|
Not at all |
41 | 55% |
|
Cost
Paid out of pocket
Cost of Oxycontin
$200+ |
6 | 11% |
|
|---|---|---|---|
$100-199 |
1 | 2% |
|
$50-99 |
6 | 11% |
|
$25-49 |
13 | 25% |
|
< $25 |
26 | 49% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.